Search Results - "Stefan, Tammy"
-
1
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression
Published in Leukemia (01-10-2021)“…The prognosis of most patients with AML is poor due to frequent disease relapse. The cause of relapse is thought to be from the persistence of leukemia…”
Get full text
Journal Article -
2
GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation
Published in Cancer research (Chicago, Ill.) (01-05-2016)“…1,25-dihydroxyvitamin D3 (1,25D), the biologically active form of vitamin D, is widely considered a promising therapy for acute myeloid leukemia (AML) based on…”
Get full text
Journal Article -
3
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia
Published in Frontiers in oncology (10-03-2020)“…Glycogen synthase kinase-3 (GSK3) inhibitors induce differentiation and growth inhibition of acute myeloid leukemia (AML) cells. Our pre-clinical studies…”
Get full text
Journal Article -
4
Dynamic epitope expression from static cytometry data: principles and reproducibility
Published in PloS one (08-02-2012)“…An imprecise quantitative sense for the oscillating levels of proteins and their modifications, interactions, and translocations as a function of the cell…”
Get full text
Journal Article -
5
Cyclin B1 is rate limiting but not essential for mitotic entry and progression in mammalian somatic cells
Published in Cell cycle (Georgetown, Tex.) (01-05-2008)“…Cyclin B1 should have some rate limiting function for cell cycle progression. To test this, we measured the effect of siRNA-mediated depletion of cyclin B1 on…”
Get full text
Journal Article -
6
Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells
Published in Frontiers in oncology (01-01-2013)“…Up to 40% of women with ovarian cancer have short disease-free intervals due to molecular mechanisms of chemotherapy resistance. New therapeutic strategies are…”
Get full text
Journal Article -
7
Analysis of the multiparametric cell cycle data
Published in Methods in cell biology (2024)“…This chapter was originally written in 2011. The idea was to give some history of cell cycle analysis before and after flow cytometry became widely accessible;…”
Get full text
Journal Article -
8
Abstract 3295: Combining GSK3 inhibition and Vitamin D as a differentiation strategy for AML
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Vitamin D has widely been considered a promising therapy for cancer, particularly Acute Myeloid Leukemia (AML), due to its ability to terminally differentiate…”
Get full text
Journal Article -
9
Multiparameter Cell Cycle Analysis
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2018)“…Cell cycle cytometry and analysis are essential tools for studying cells of model organisms and natural populations (e.g., bone marrow). Methods have not…”
Get more information
Journal Article -
10
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies
Published in Cytometry. Part B, Clinical cytometry (01-01-2024)“…The 5‐azacytidine (AZA) and decitabine (DEC) are noncytotoxic, differentiation‐inducing therapies approved for treatment of myelodysplastic syndrome, acute…”
Get full text
Journal Article -
11
Ribonucleotide Reductase Inhibition Enhances Chemoradiosensitivity of Human Cervical Cancers
Published in Radiation research (01-11-2010)“…For repair of damaged DNA, cells increase de novo synthesis of deoxyribonucleotide triphosphates through the rate-limiting, p53-regulated ribonucleotide…”
Get full text
Journal Article -
12
Glycogen Synthase Kinase-3 (GSK3) Inhibition with Lithium in Combination with Tretinoin Induces Differentiation in Non-Promyelocytic Acute Myeloid Leukemia (AML)
Published in Blood (03-12-2015)“…Lithium (Li) is a GSK3 inhibitor that induces differentiation and anti-proliferation of AML cells in vitro. Pre-clinical studies demonstrated GSK3 inhibition…”
Get full text
Journal Article -
13
Multiparameter cell cycle analysis
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2011)“…Cell cycle-related cytometry and analysis is an essential experimental paradigm for the cell biology of yeast, mammalian, and drosophila cells. Methods have…”
Get more information
Journal Article -
14
All-Trans-Retinoic Acid (ATRA) Combined with Lithium As Treatment of Relapsed Non-Progranulocytic AML: Therapeutic Targeting Inhibition of the Glycogen Synthase Kinase 3-Beta (GSK3) Enzyme
Published in Blood (06-12-2014)“…Introduction: Targeting the maturation arrest in acute myeloid leukemia (AML) to induce differentiation instead of killing rapidly dividing cells can lead to…”
Get full text
Journal Article -
15
Laser Scanning Cytometry of Mitosis: State and Stage Analysis
Published in Methods in Cell Biology (2011)“…Here we use a concept of cell state, which can be defined as the conjunction of expression levels of an arbitrary number of biomolecules or modifications…”
Get full text
Book Chapter Journal Article -
16
Cell Cycle Arrest by Kynurenine in Lens Epithelial Cells
Published in Investigative ophthalmology & visual science (01-12-2008)“…Indolemine 2,3-dioxygenase (IDO)-mediated oxidation of tryptophan produces kynurenines (KYNs), which may play a role in cataract formation. The molecular…”
Get full text
Journal Article -
17
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies
Published in Cancer chemotherapy and pharmacology (01-06-2012)“…Purpose Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common. Flavopiridol, a cyclin-dependent kinase (CDK) inhibitor,…”
Get full text
Journal Article -
18
A new biomarker for mitotic cells
Published in Cytometry. Part A (01-01-2008)“…Many epitopes are phosphorylated during mitosis. These epitopes are useful biomarkers for mitotic cells. The most commonly used are MPM‐2 and serine 10 of…”
Get full text
Journal Article -
19
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl^sup +^ hematological malignancies
Published in Cancer chemotherapy and pharmacology (01-06-2012)“…Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common. Flavopiridol, a cyclin-dependent kinase (CDK) inhibitor, down-regulates…”
Get full text
Journal Article -
20
Determination of O 6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography
Published in Journal of chromatography. Biomedical applications (07-06-1996)“…A high-performance liquid chromatographic assay for O 6-benzylguanine utilizing liquid-liquid extraction and reversed-phase chromatography has been developed…”
Get full text
Journal Article